Scientists test new drug cocktail to fight advanced colon and pancreatic cancers
Disease control
Completed
This early-stage trial tested a new oral drug, ERAS-007, in combination with other cancer therapies for people with advanced colorectal or pancreatic cancer. The main goals were to find the safest and most effective dose and to see if the drug combinations could shrink tumors. Th…
Phase: PHASE1, PHASE2 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC